X4 Pharmaceuticals XFOR
NASDAQ XFOR
$2.83 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

X4 Pharmaceuticals (XFOR) Non Operating Investment Income (2019 - 2024)

Updated

X4 Pharmaceuticals' Non Operating Investment Income came in at $105 million for FY2024.

Analysis

X4 Pharmaceuticals (XFOR) Non Operating Investment Income (2019 - 2024) Analysis & Trends

  • The FY2024 figure represents the lowest annual Non Operating Investment Income since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 X4 Pharmaceuticals 357.55 Mn -341.13 Mn 7.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 105.00 Mn
Dec 31, 2022 -509,000.00
Mar 31, 2022 509,000.00
Dec 31, 2019 104,000.00
Sep 30, 2019 -4.00 Mn
API Access

X4 Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=XFOR&period=max&api_key=YOUR_API_KEY